BioNTech SE News
Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing
“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Cramer's Mad Money Recap 5/18: Target, Walmart, Wingstop
Jim Cramer cautions that knowing when the bottom has arrived and knowing when to buy back into the market is never easy. Don't risk missing out.
New Biotech Startup Looks to Take On Pfizer, Moderna
Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.
Moderna Stock Surges On Q4 Earnings Beat, 2022 Covid Vaccine Sales Boost
Moderna said it now sees sales of Spikevax rising to $19 billion this year, with additional signed options of approximately $3 billion.
Pfizer Beats Q4 Earnings Forecast, Sees $54 Billion In 2022 Covid Sales; Stock Slides
Pfizer said combined sales of its Covid vaccine and treatment drugs would rise to $54 billion this year, around half of its total projected revenues.
Breaking News
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll
Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.
Summers, Others Cite Growing Chance of Recession
GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.
Coinbase Faces A New Scandal
The platform denies selling proprietary customer data and announces it is expanding into several European countries.